Royalty Pharma (RPRX)
(Real Time Quote from BATS)
$28.22 USD
+0.50 (1.80%)
Updated Sep 16, 2024 11:34 AM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Cystic fibrosis franchise
- 771.20
- 811.05
- 702.14
- 551.34
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Trelegy
- 203.30
- 89.92
- --
- --
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Tysabri
- 279.43
- 369.79
- 369.15
- 345.85
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Imbruvica
- 210.29
- 312.69
- 352.91
- 322.07
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Evrysdi
- 66.07
- 40.65
- 16.10
- 0.27
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Promacta
- 161.16
- 181.63
- 173.62
- 143.74
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Xtandi
- 146.42
- 186.70
- 158.10
- 146.37
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Tremfya
- 116.39
- 97.31
- 35.72
- --
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Cabometyx/Cometriq
- 65.78
- 55.43
- 33.72
- --
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Trodelvy
- 33.15
- 24.81
- 13.40
- 3.03
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Erleada
- 27.38
- 21.38
- 14.23
- 7.88
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Orladeyo
- 29.34
- 21.80
- 6.74
- --
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Other Growth Products
- 276.51
- 262.74
- 404.02
- 310.51
- --
- Revenue - Line of Business (LOBR)
- Revenue: Royalty Receipts: Growth Products: Nurtec ODT
- 18.38
- 559.62
- 70.19
- 3.67
- --
- Revenue - Line of Business (LOBR)
- Revenue: Total Royalty Receipts: Growth Products
- 2,449.42
- 3,231.26
- 2,608.54
- 2,344.40
- --